BRWA
ATXI

B. Riley Wealth Advisors’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

B. Riley Wealth Advisors’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-52
Closed -$16K – 1549
2022
Q2 		$16K Sell
52
-2
-4% -$770 ﹤0.01% 1210
2022
Q1 		$30K Sell
54
-9
-14% -$6.73K ﹤0.01% 1350
2021
Q4 		$65K Sell
63
-16
-20% -$23.1K ﹤0.01% 1365
2021
Q3 		$133K Sell
79
-33
-29% -$68.2K ﹤0.01% 1302
2021
Q2 		$317K Sell
112
-40
-26% -$197K 0.01% 996
2021
Q1 		$1.03M Buy
152
+3
+2% +$20.6K 0.04% 470
2020
Q4 		$999K Buy
149
+19
+15% +$99.6K 0.05% 329
2020
Q3 		$1.58M Buy
130
+39
+43% +$474K 0.08% 242
2020
Q2 		$1.1M Buy
91
+6
+7% +$67.7K 0.07% 264
2020
Q1 		$859K Buy
85
+17
+25% +$170K 0.07% 264
2019
Q4 		$732K Buy
68
+2
+3% +$14K 0.06% 309
2019
Q3 		$440K Buy
66
+8
+14% +$54.5K 0.04% 446
2019
Q2 		$408K Buy
58
+5
+9% +$28.9K 0.04% 450
2019
Q1 		$282K Sell
53
-6
-10% -$38.3K 0.04% 525
2018
Q4 		$358K Buy
59
+3
+5% +$14.4K 0.05% 390
2018
Q3 		$179K Buy
56
+2
+4% +$8.21K 0.02% 658
2018
Q2 		$220K Sell
54
-1
-2% -$4.64K 0.03% 581
2018
Q1 		$281K Buy
55
+6
+12% +$29.7K 0.04% 476
2017
Q4 		$201K Buy
49
+36
+277% +$184K 0.03% 583
2017
Q3 		$83K Buy
+13
New +$95.4K 0.01% 522

Other funds holding ATXI

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

B. Riley Wealth Advisors's ATXI Position: Q3 2022 in Review

B. Riley Wealth Advisors sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q3 2022, closing a stake of 52 shares — an estimated $16K sold.

B. Riley Wealth Advisors first reported a position in ATXI in Q3 2017 and held it in 20 quarters. The position peaked at $1.58M in Q3 2020. 10 funds tracked by Wall St. Rank hold ATXI as of Q3 2022.

  • B. Riley Wealth Advisors reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 52 Avenue Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $16K.
  • B. Riley Wealth Advisors first reported a position in Avenue Therapeutics, Inc. Common Stock in Q3 2017 and held it in 20 quarters.
  • B. Riley Wealth Advisors's Avenue Therapeutics, Inc. Common Stock position peaked at $1.58M in Q3 2020.
  • 10 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q3 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.